Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin

Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin

US Patent 9234021 · Granted Jan 12, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered leucine decarboxylases2025
Engineered acid alpha-glucosidase variants2025
Fusion proteins comprising an engineered knottin peptide and uses thereof2025
Fusion proteins comprising an engineered knottin peptide and uses thereof2025
Methods of engineering transferrin receptor binding polypeptides2024
Soluble leukemia inhibitory factor receptor polypeptides and methods of using sa2024
Methods and systems for screening using microcapillary arrays2024
Compositions and methods for treatment of bone associated diseases2024
Engineered acid alpha-glucosidase variants2024
Anti-ApoE antibodies2024
Methods of engineering transferrin receptor binding polypeptides2024
Fusion proteins comprising enzyme replacement therapy enzymes2024